RAD BUY ?RAD testing weekly 2/1. Should the price break and closes above 2/1 then which suggest stock is bullish ?
RAD
RAD - DAILY CHART Hi, today we are going to talk about Rite Aid and its current landscape.
Rite Aid is poised to receive increasing attention from the market as relevant events are taking place. The American drugstore chain issued better than expected EPS, and sales results for its third-quarter report also raised its fiscal-year EPS guidance above estimates. Positive news that can be attributed to the company's efforts to deploy its new strategy, which includes investment into its pharmacy benefit manager.
Thank you for reading and leave your comments if you like.
To have access to our exclusive contents, join the Traders Heaven today! Link Below.
Disclaimer: All content of Golden Dragon has only educational and informational purposes, and never should be used or take it as financial advice.
$RAD Looking To Reverse The Downtrend$RAD is showing signs of bullishness after breaking out to the upside above $11. With the charts showing an inverse head and shoulders pattern, we believe the worse is over for $RAD. Shares are also now trading above the 200 day moving average of $9.76 a share.
Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. The company operates through two segments, Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment sells prescription drugs and an assortment of other merchandise, including over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, and other every day and convenience products. It also operates retail clinics that provide treatment for common conditions; and provides preventative services, such as screenings, medical tests, immunizations, and basic physical exams. In addition, this segment offers healthcare coaching and disease management services. The Pharmacy Services segment provides pharmacy benefit management (PBM) services and a range of pharmacy-related services. This segment also performs prescription adjudication services for other PBMs; and offers integrated mail-order and specialty pharmacy services, as well as drug benefits under the federal government's Medicare Part D program. As of April 11, 2019, the company operated 2,469 stores in 18 states. Rite Aid Corporation was founded in 1927 and is headquartered in Camp Hill, Pennsylvania.
As always, trade with caution and use protective stops.
Good luck to all!
Flipped Long on $RADvery strong bounce off of ~$6.50 support. Is this the start of a macro bull cycle for RiteAid as history showed?
$RAD got rejected hard at ~$10 I flipped short just in time earlier this morning. I think RiteAid will definitely test $6 daily support as best case scenario. Worst case scenario imo is $4.50-5 and then it hits that yellow monthly trend-line.
RiteAid is about to explode Pretty self explanatory, strong reaction to the upside every time it touched yellow trend line. looks like it is setting up to do that within this month or the next.
RAD - Not even close to being doneDoes this look like it's ready to breakout yet? 2 clean rejections, and not even near the end of the coil. Go back to 2008.
RAD - Sharp Rejection at Trendline but Will Likely Retest AgainThe touch at $0.81 shows it is not ready for a breakout quite yet. This reaction was at the long time trendline resistance.
Short term: it did the same thing. I think it's safe to assume it will go back up to retest it again and hopefully get to the 50.
Long-term: Look for a break above $1 after we coil down a bit more.
Bearish beautiful S-curve 15min on RADMy thoughts on RAD: puts sale with this 15 minutes S-curve...
only my plan.
Rite Aid Wedge Reversal forming and MACD crossoverbuy at the bottom of crossover.
Sell Target: $2.60
RAD wedge pattern points upwardRAD pharmaceuticals has been in a downtrend and indicated by the reversal in trend plus my analysis, shows a wedge form showing the bulls are ready to step in.
RAD - Channel breakout long from $2.34 to $3.93RAD seems breaking out a triangle formation in the short term & in the long term it is breaking out a downward channel formation. We think it will continue from here as the breakout was with strong volume.
* Trade Criteria *
Date First Found- January 11, 2018
Pattern/Why- Possible momentum play
Entry Target Criteria- Current price ($2.34)
Exit Target Criteria- 1st target $2.93, 2nd Target- $3.93
Stop Loss Criteria- $2.18
Please check back for Trade updates. (Note: Trade update is little delayed here.)
Sep 28 Earnings: Rite Aid - Way Oversold, Earnings Will SurpriseThe company's share price has been under severe pressure since the deal with Walgreens $WBA has fallen through and low pharmacy reimbursement rates.
Rite Aid's organic growth remains impressive, posting double digit sales growth in 2016. Earnings should get a boost from aggressive cost cutting measures.
I believe the company's share price is way oversold and earnings revisions should prove fruitful in the next 6 months.
I'm initiating the company with a $3.50 PT for the post-earnings move and upward of $4.00 heading into 2018.
PLUG LONG BUYGeorge McNamee, chairman of Plug Power's board of directors, purchased 200,000 shares of Plug stock worth more than $426,000 in September.
McNamee now owns 661,131 shares of Plug’s common stock, according to a U.S. Securities and Exchange Commission disclosure filed on Monday.
CEO Andy Marsh has been working to make Plug profitable for the first time in 20 years. He came to Plug Power in 2008 with an overhauled business plan and has spent the last nine years converting Plug from a research company into a manufacturer. (bizjournals.com)